Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IDYA
IDYA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IDYA News
IDEAYA Biosciences Initiates Phase 1 Clinical Trial for IDE849 and IDE161
1d ago
PRnewswire
IDEAYA Biosciences Advances Clinical Trials for IDE849 and IDE161
1d ago
Newsfilter
IDEAYA Grants 49,000 Stock Options to New Employees
4d ago
PRnewswire
IDEAYA Grants Stock Options to New Employees
4d ago
Newsfilter
IDEAYA Biosciences Delays Data Release for Eye Cancer Trial
Mar 23 2026
seekingalpha
IDEAYA Biosciences Announces Upcoming Investor Relations Events
Mar 22 2026
PRnewswire
IDEAYA Biosciences Updates Guidance on Clinical Trial Data Release
Mar 22 2026
Newsfilter
IDEAYA Biosciences Announces AACR Poster Presentations on Innovative Cancer Therapies
Mar 18 2026
PRnewswire
IDEAYA Biosciences Announces AACR Poster Presentations
Mar 18 2026
Newsfilter
IDEAYA Initiates Phase 1 Trial for IDE892
Mar 09 2026
PRnewswire
Biocytogen and IDEAYA Advance New Drug Clinical Trial
Feb 28 2026
Newsfilter
IDEAYA Grants 346,200 Stock Options to New Employees
Feb 27 2026
PRnewswire
IDEAYA Grants 346,200 Stock Options to New Employees
Feb 27 2026
Newsfilter
IDEAYA Biosciences Initiates Phase 1 Trial for IDE034
Feb 25 2026
PRnewswire
IDEAYA Initiates Phase 1 Trial for IDE034
Feb 25 2026
Newsfilter
IDEAYA Appoints New Chief Development Officer
Feb 23 2026
PRnewswire
Show More News
